Pretreatment method for biological sample containing keto-enol tautomer drug and a sample pretreated thereby and quantitative analysis method for the pretreated sample

The present invention relates to a pretreatment method of a biological sample containing a keto-enol convertor drug, a sample pretreated thereby, and a quantitative analysis method for the pretreated sample and, more specifically, to a method for treating a biological sample containing a keto-enol c...

Full description

Saved in:
Bibliographic Details
Main Authors YOON YOO JEONG, KIM JI YEONG, KO SUK YEN, YUN MIN HYUK
Format Patent
LanguageEnglish
Korean
Published 27.10.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to a pretreatment method of a biological sample containing a keto-enol convertor drug, a sample pretreated thereby, and a quantitative analysis method for the pretreated sample and, more specifically, to a method for treating a biological sample containing a keto-enol convertor drug, which exists as mainly a reducing agent in vivo after drug administration even though the drug itself is an oxide object like a quinone-based drug, by an oxidizing agent and then incubating it to be pretreated, a sample pretreated thereby, and a quantitative analysis method for the pretreated sample. 본 발명은 케토-엔올 변환체 약물을 함유하는 생체 시료의 전처리 방법 및 이에 의하여 전처리된 시료, 및 이 전처리 시료에 대한 정량 분석 방법에 관한 것으로, 보다 상세하게는, 퀴논계 약물과 같이 약물 자체는 산화체이지만 약물 투여후 생체 내에서는 주로 환원체로 존재하는 케토-엔올 변환체 약물을 함유하는 생체 시료를 산화제로 처리한 후 인큐베이션하여 전처리하는 방법 및 이에 의하여 전처리된 시료, 및 이 전처리 시료를 정량 분석하는 방법에 관한 것이다.
Bibliography:Application Number: KR20210050581